Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 586-593, 2003; 10.1373/49.4.586
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meijer, W. G.
Right arrow Articles by de Vries, E. G.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meijer, W. G.
Right arrow Articles by de Vries, E. G.E.
Related Collections
Right arrow Cancer Diagnostics (since 2002)
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:586-593.)
© 2003 American Association for Clinical Chemistry, Inc.

Catecholamine-Synthesizing Enzymes in Carcinoid Tumors and Pheochromocytomas

Wim G. Meijer1, Sjef C.V.M. Copray2, Harry Hollema3, Ido P. Kema3, Nynke Zwart1, Ietje Mantingh-Otter2, Thera P. Links4, Pax H.B. Willemse1 and Elisabeth G.E. de Vries1,a

Departments of
1 Medical Oncology,
2 Medical Physiology,
3 Pathology and Laboratory Medicine, and
4 Endocrinology, University Hospital Groningen, 9700 RB Groningen, The Netherlands.

aAddress correspondence to this author at: Department of Medical Oncology, University Hospital, PO Box 30.001, 9700 RB Groningen, The Netherlands. Fax 31-503614862; e-mail e.g.e.de.vries{at}int.azg.nl.

Background: Serotonin is the principal endocrine product of carcinoid tumors, but simultaneously increased production of catecholamines has been described in these tumors. As it is not clear whether these tumors contain specific enzymes for catecholamine synthesis, we aimed to detect catecholamine-synthesizing enzymes [tyrosine hydroxylase (TH), dopamine-ß-hydroxylase (DBH), and phenylethanolamine-N-methyltransferase (PNMT)] in midgut carcinoid tumors and pheochromocytoma and to correlate enzyme expression to serotonin production as well as catecholamines and metabolites excreted in urine.

Methods: Paraffin-embedded tumor specimens from 21 midgut carcinoid patients and 20 pheochromocytoma patients (10 sporadic and 10 MEN type IIa-related tumors) were stained for TH, DBH, and PNMT, using a three-step biotin-avidin-peroxidase method.

Results: TH was demonstrated in 9 (43%) of 21 carcinoids and in all (100%) of 20 pheochromocytomas, DBH in 8 (38%) carcinoids and in 15 (75%) pheochromocytomas, and PNMT in 7 (33%) carcinoids and in 13 (65%) pheochromocytomas. Increased urinary excretion of catecholamines and metabolites was observed in 10 (48%) carcinoid patients and in all pheochromocytoma patients. No clinically relevant association between enzyme expression and urinary excretion of catecholamines and metabolites was found.

Conclusions: Catecholamine-synthesizing enzymes are present in many carcinoid tumors. This finding possibly indicates the existence of a catecholamine-synthesizing pathway in carcinoids similar to that found in pheochromocytoma.




The following articles in journals at HighWire Press have cited this article:


Home page
 JNMHome page
P. L. Jager, R. Chirakal, C. J. Marriott, A. H. Brouwers, K. P. Koopmans, and K. Y. Gulenchyn
6-L-18F-Fluorodihydroxyphenylalanine PET in Neuroendocrine Tumors: Basic Aspects and Emerging Clinical Applications
J. Nucl. Med., April 1, 2008; 49(4): 573 - 586.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. P. Koopmans, O. C. Neels, I. P. Kema, P. H. Elsinga, W. J. Sluiter, K. Vanghillewe, A. H. Brouwers, P. L. Jager, and E. G.E. de Vries
Improved Staging of Patients With Carcinoid and Islet Cell Tumors With 18F-Dihydroxy-Phenyl-Alanine and 11C-5-Hydroxy-Tryptophan Positron Emission Tomography
J. Clin. Oncol., March 20, 2008; 26(9): 1489 - 1495.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
H. J.L.M. Timmers, M. Hadi, J. A. Carrasquillo, C. C. Chen, L. Martiniova, M. Whatley, A. Ling, G. Eisenhofer, K. T. Adams, and K. Pacak
The Effects of Carbidopa on Uptake of 6-18F-Fluoro-L-DOPA in PET of Pheochromocytoma and Extraadrenal Abdominal Paraganglioma
J. Nucl. Med., October 1, 2007; 48(10): 1599 - 1606.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
C. M. Intenzo, S. Jabbour, H. C. Lin, J. L. Miller, S. M. Kim, D. M. Capuzzi, and E. P. Mitchell
Scintigraphic Imaging of Body Neuroendocrine Tumors
RadioGraphics, September 1, 2007; 27(5): 1355 - 1369.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. P. Koopmans, A. H. Brouwers, M. N. De Hooge, A. N. Van der Horst-Schrivers, I. P. Kema, B. H. Wolffenbuttel, E. G. De Vries, and P. L. Jager
Carcinoid Crisis After Injection of 6-18F-Fluorodihydroxyphenylalanine in a Patient with Metastatic Carcinoid
J. Nucl. Med., July 1, 2005; 46(7): 1240 - 1243.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.